Monografie
Generation of colo rectal cancer targeting TRAIL fusion proteins and a mesenchymal stem cell line for in situ expression of these proteins
- Sprache
-
Englisch
- Identifier
-
1132134447
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
- DOI
-
10.18419/opus-9125
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Objekttyp
- Monografie
Beteiligte
- Marini, Irene
- Pfizenmaier, Klaus
Ähnliche Objekte (12)
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Metabolic and transcriptomic response to hyperosmotic stimulus reveals strategies for optimization of antibody producing Chinese hamster ovary cells
Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP
Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity
Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential
Sensitivierung des Malignen Melanoms gegenüber TRAIL in einem organotypischen Tumor-Testsystem
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex
Die Rolle des p53-Status für die Sensitivität von Tumoren gegenüber unterschiedlichen p53 Aktivatoren
Inhibition des PI3K-AKT-mTOR-Signalwegs zur Überwindung der Therapieresistenz beim malignen Melanom
Bifunctional immunostimulatory fusion proteins for therapeutic applications
A global microRNA screen identifies regulators of the ErbB receptor signaling network
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Metabolic and transcriptomic response to hyperosmotic stimulus reveals strategies for optimization of antibody producing Chinese hamster ovary cells
Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP
Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity
Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential
Sensitivierung des Malignen Melanoms gegenüber TRAIL in einem organotypischen Tumor-Testsystem
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex
Die Rolle des p53-Status für die Sensitivität von Tumoren gegenüber unterschiedlichen p53 Aktivatoren
Inhibition des PI3K-AKT-mTOR-Signalwegs zur Überwindung der Therapieresistenz beim malignen Melanom
Bifunctional immunostimulatory fusion proteins for therapeutic applications
A global microRNA screen identifies regulators of the ErbB receptor signaling network
Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targeting
Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer
Metabolic and transcriptomic response to hyperosmotic stimulus reveals strategies for optimization of antibody producing Chinese hamster ovary cells
Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP
Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity
Generation of "LYmph Node Derived Antibody Libraries" (LYNDAL) : a concept for recovering human monoclonal antibodies with therapeutic potential
Sensitivierung des Malignen Melanoms gegenüber TRAIL in einem organotypischen Tumor-Testsystem
Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex
Die Rolle des p53-Status für die Sensitivität von Tumoren gegenüber unterschiedlichen p53 Aktivatoren
Inhibition des PI3K-AKT-mTOR-Signalwegs zur Überwindung der Therapieresistenz beim malignen Melanom
Bifunctional immunostimulatory fusion proteins for therapeutic applications